Back to User profile » Dr Maurie Markman

Papers published by Dr Maurie Markman:

Case report

Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden

Parikh AR, Ali SM, Schrock AB, Albacker LA, Miller VA, Stephens PJ, Crilley P, Markman M

Lung Cancer: Targets and Therapy 2018, 9:45-47

Published Date: 18 May 2018

Original Research

Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients

Niu J, Andres G, Kramer K, Kundranda MN, Alvarez RH, Klimant E, Parikh AR, Tan B, Staren ED, Markman M

OncoTargets and Therapy 2015, 8:3323-3328

Published Date: 11 November 2015

Original Research

The relationship between patient satisfaction with service quality and survival in pancreatic cancer

Gupta D, Markman M, Rodeghier M, Lis CG

Patient Preference and Adherence 2012, 6:765-772

Published Date: 1 November 2012

Review

Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer

Markman M

Cancer Management and Research 2011, 3:219-225

Published Date: 13 June 2011

Review

Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin

Maurie Markman

Therapeutics and Clinical Risk Management 2009, 5:161-168

Published Date: 2 February 2009